DocDollars

Azurity Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000316828

Total reported 2019–2025
$9.74M
#496 of 2,960 reporting companies — 0% of all reported industry payments
$979K in general payments across 34,888 records, plus $8.76M in research funding across 147 records.

How it breaks down

General payments $979,246
Research funding $8,762,149

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Azurity Pharmaceuticals, Inc. reported $9.74M to US doctors and teaching hospitals from 2019 to 2025, ranking #496 of 2,960 reporting companies. 90% of that was research funding and 10% general payments such as consulting, speaking, food and travel. 34,888 general payment records and 147 research records were filed.

Common questions about Azurity Pharmaceuticals, Inc.

How much has Azurity Pharmaceuticals, Inc. paid US doctors?

Azurity Pharmaceuticals, Inc. reported $9,741,395 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $979,246 in general payments, $8,762,149 in research funding.

How does Azurity Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #496 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Azurity Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.